Crossmark

Development of a novel diagnostic model to monitor the progression of metabolic dysfunction-associated steatotic liver disease to hepatocellular carcinoma in females

Crossref DOI link: https://doi.org/10.1007/s12672-024-01636-3

Published Online: 2024-12-19

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gan, Xiaoning

Zhou, Yun

Li, Yonghao

Xu, Lin

Liu, Guolong https://orcid.org/0000-0002-8336-1703
Funding

Funding for this research was provided by:

The National Natural Science Foundation of China (82103103)

the Key Project of Scientific and Technological Bureau of Guangzhou City (202201020335)
License Information

Text and Data Mining valid from 2024-12-19

Version of Record valid from 2024-12-19
More Information

Article History

Received: 20 January 2024

Accepted: 26 November 2024

First Online: 19 December 2024

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below